MiMedx Group Inc (MDXG)

NASDAQ
11.82
+0.22(+1.90%)
  • Volume:
    302,052
  • Bid/Ask:
    9.51/12.00
  • Day's Range:
    11.60 - 12.02

MDXG Overview

Prev. Close
11.6
Day's Range
11.6-12.02
Revenue
246.47M
Open
11.75
52 wk Range
5.32-13.01
EPS
-0.81
Volume
302,052
Market Cap
1.32B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,548,084
P/E Ratio
-
Beta
1.64
1-Year Change
114.91%
Shares Outstanding
111,718,544
Next Earnings Date
Aug 03, 2021
What is your sentiment on MiMedx Group Inc?
or
Market is currently closed. Voting is open during market hours.

MiMedx Group Inc News

MiMedx Group Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Buy
SummaryStrong SellSellStrong BuyStrong BuyStrong Buy

MiMedx Group Inc Company Profile

MiMedx Group Inc Company Profile

MiMedx Group, Inc. is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company's Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories. Its biomaterial platform technologies include AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix. AmnioFix and EpiFix are its tissue technologies processed from human amniotic membrane derived from donated placentas. OrthoFlo is amniotic fluid-derived allograft for homologous use. Physio is a bone grafting material consists of bone tissue with no added carrier. CollaFix, its new brand, is its collagen fiber technology designed to mimic the natural composition, structure and mechanical properties of musculoskeletal tissues in order to augment their repair.

Read More
  • https://www.presciencepoint.com/research/research-archives/mimedx/. . . READ
    0
    • gap up to zero. no financials, no cash, no future but lawsuits
      1
      • spoken like someone who has no clue
        0
    • $mdxg going to gap up. $15 must
      1
      • Lol you couldn’t possibly be more wrong
        0
    • The trend is super bullish.
      1
      • I am refinancing my house and will buy more soon. Not selling until $15.
        1
        • Im sorry for your loss
          0
      • $10 coming soon
        0
        • CEO and COO resign and investigation of accounting continues
          0
          • today it dropped to $4.20
            0
            • Short now
              0
              • mDXG is a big buy with 42% upside to a current price at $8.07
                1
                • Seems you were correct
                  1
                • For a while...
                  0
              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.